scholarly article | Q13442814 |
P356 | DOI | 10.1016/0002-9378(90)91323-5 |
P698 | PubMed publication ID | 2158235 |
P2093 | author name string | Pater A | |
Pater MM | |||
Bayatpour M | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1099-1103 | |
P577 | publication date | 1990-04-01 | |
P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
P1476 | title | Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. | |
P478 | volume | 162 |
Q40438662 | 1 Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus |
Q50700490 | A retrospective study on cervical intraepithelial lesions of low-grade and undetermined significance: evolution, associated factors and cytohistological correlation. |
Q40853429 | Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone |
Q51029221 | Contraceptive use and reproductive history in women with cervical human papillomavirus infection. |
Q37267830 | Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection |
Q36687378 | Efficacy trial of topically administered interferon gamma-1? gel in comparison to laser treatment in cervical intraepithelial neoplasia |
Q67699937 | Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues |
Q35614578 | HPV prevalence and concordance in the cervix and oral cavity of pregnant women |
Q35831422 | Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix |
Q77747953 | Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III) |
Q41349357 | Human papillomavirus infection in women. Special aspects of infectious diseases in women |
Q41438690 | Human papillomaviruses and cervical cancer |
Q37255166 | Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors. |
Q42462920 | Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix |
Q35562045 | Influence of ovarian hormones on urogenital infection |
Q45761353 | Is breast cancer caused by late exposure to a common virus? |
Q36652482 | Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions |
Q44993791 | Mutations in the ras protooncogenes are rare events in renal cell cancer |
Q35533508 | Noncontraceptive benefits of modern low-dose oral contraceptives |
Q67505364 | Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia |
Q33934353 | Pathogenesis of genital HPV infection. |
Q60654488 | Prevalence and persistence of human papillomavirus in postmenopausal age women |
Q72095656 | Quantification of HPV‐16 E6‐E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction |
Q35040082 | Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma |
Q40479366 | Review human papillomaviruses (HPV) in gynaecological cytology: from molecular biology to clinical testing |
Q44814193 | Risk factors for cervical cancer in Colombia and Spain |
Q34448400 | Role of nuclear progesterone receptor isoforms in uterine pathophysiology |
Q33934843 | The detection of HPV DNA, the size of tampon specimens and the menstrual cycle. |
Q40989058 | The epidemiology of cervical carcinogenesis |
Q41301893 | The genetic program of genital human papillomaviruses in infection and cancer |
Q41653500 | The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis. |
Q53402217 | The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. |
Q57561057 | Time since last use of oral contraceptives and risk of invasive cervical cancer |
Search more.